GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SNYR · Dec 31, 2024

Synergy CHC Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001213900-25-026254General Corporate
Operating cash generation10thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-13.79% · OPTIONAL · VALID

Inventory pressure5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

4.93% · OPTIONAL · VALID

Gross margin25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

67.87% · CORE · VALID

Operating margin75thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

16.65% · CORE · VALID

SBC intensity0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.00% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Period transition

What moved in the state?

Inventory Pressure Decreased
Previous
26.81%
Current
4.93%
Delta
-21.88%
Margin Increased
Previous
67.22%
Current
67.87%
Delta
0.65%
Profitability Increased
Previous
14.75%
Current
16.65%
Delta
1.91%
Sbc Intensity Decreased
Previous
0.06%
Current
0.00%
Delta
-0.06%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.